Skip to content
10-Q

Quarterly Report

Bolt Biotherapeutics, Inc. BOLT

0001641281-25-000007

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 7, 2025 1.92M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.92M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.92M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 1.91M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 1.91M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$22.96M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$32.89M
Short Term Investments Q2 2025 · Jun 30, 2025 $25.17M
Short Term Investments Q2 2025 · Dec 31, 2024 $40.12M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $9.6M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $7.21M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $6.2M
Stockholders Equity Q2 2025 · Jun 30, 2025 $38.84M
Stockholders Equity Q2 2025 · Mar 31, 2025 $46.81M
Stockholders Equity Q2 2025 · Dec 31, 2024 $57.2M
Stockholders Equity Q2 2025 · Jun 30, 2024 $85.86M
Stockholders Equity Q2 2025 · Mar 31, 2024 $104.16M
Stockholders Equity Q2 2025 · Dec 31, 2023 $112.74M
Current Liabilities Q2 2025 · Jun 30, 2025 $12.31M
Current Liabilities Q2 2025 · Dec 31, 2024 $15.86M
Total Liabilities Q2 2025 · Jun 30, 2025 $36.66M
Total Liabilities Q2 2025 · Dec 31, 2024 $42.43M
Current Assets Q2 2025 · Jun 30, 2025 $38.34M
Current Assets Q2 2025 · Dec 31, 2024 $50.81M
Total Assets Q2 2025 · Jun 30, 2025 $75.5M
Total Assets Q2 2025 · Dec 31, 2024 $99.63M
Eps Diluted Q2 2025 · Jun 30, 2025 −$4.46
Eps Diluted Q2 2025 · Jun 30, 2025 −$10.22
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$11.12
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$16.80
Eps Basic Q2 2025 · Jun 30, 2025 −$4.46
Eps Basic Q2 2025 · Jun 30, 2025 −$10.22
Eps Basic restated Q2 2025 · Jun 30, 2024 −$11.12
Eps Basic restated Q2 2025 · Jun 30, 2024 −$16.80
Sga Expense Q2 2025 · Jun 30, 2025 $3.52M
Sga Expense Q2 2025 · Jun 30, 2025 $7.34M
Sga Expense Q2 2025 · Jun 30, 2024 $4.87M
Sga Expense Q2 2025 · Jun 30, 2024 $10.71M
Rd Expense Q2 2025 · Jun 30, 2025 $7.5M
Rd Expense Q2 2025 · Jun 30, 2025 $17.01M
Rd Expense Q2 2025 · Jun 30, 2024 $15.43M
Rd Expense Q2 2025 · Jun 30, 2024 $31.96M
Net Income Q2 2025 · Jun 30, 2025 −$8.56M
Net Income Q2 2025 · Jun 30, 2025 −$19.6M
Net Income Q2 2025 · Jun 30, 2024 −$21.2M
Net Income Q2 2025 · Jun 30, 2024 −$32.01M
Operating Income Q2 2025 · Jun 30, 2025 −$9.21M
Operating Income Q2 2025 · Jun 30, 2025 −$21.33M
Operating Income Q2 2025 · Jun 30, 2024 −$22.6M
Operating Income Q2 2025 · Jun 30, 2024 −$39.69M
Revenue Q2 2025 · Jun 30, 2025 $1.8M
Revenue Q2 2025 · Jun 30, 2025 $3.03M
Revenue Q2 2025 · Jun 30, 2024 $1.28M
Revenue Q2 2025 · Jun 30, 2024 $6.55M